A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI’s potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering in a new era of AI-assisted medicine.
Trending
- Punjab to roll out monthly aid for women under Mawan Dheeyan Satkar Yojna from July 1
- New rule for work permit in US: Asylum seekers may lose jobs under DHS proposal
- Watch: Oil India discovers natural gas deposit in Andaman basin; Puri hails find
- Crisis on int’l space stn: Astronauts told to prepare for evacuation as air leaks worsen
- Fuel-saving push, rising costs: Is public transport affordable enough?
- Drug smugglers Baltej Singh and Himatjit Kahlon lose final bid to overturn jail terms in NZ
- NFL trade rumour: Commanders, Colts eye $4M Patriots star
- 8L volunteers within hours: Annamalai’s ‘political movement’ becomes an instant hit
World’s first AI-designed vaccine developed by UK scientists enters human trials
By
Add A Comment